H. J. Illiger

Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

Stephen Chan, M. E. Scheulen, S. Johnston et al. · Journal of Clinical Oncology · 2005 · 468 citations · Full text

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer

Volker Heinemann, H. Wilke, H.‐G. Mergenthaler et al. · Annals of Oncology · 2000 · 171 citations

Urology, Pancreatic Cancer, Gastrointestinal Oncology +5

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.

Anthony D. Ho, T. Lipp, Gerhard Ehninger et al. · Journal of Clinical Oncology · 1988 · 143 citations

Hematological Malignancy, Secondary Aml, Continuous Cr +13

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma.

Jens Atzpodien, E Lopez Hänninen, H. Kirchner et al. · Journal of Clinical Oncology · 1995 · 142 citations

Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma

H.J. Weh, H. Wilke, Judith Dierlamm et al. · Annals of Oncology · 1994 · 76 citations · Full text

Pretreated Patients, Surgical Oncology, Weekly Therapy +7